John Carroll

Lobbying state legislatures pays off for physician groups, and now health plans must provide more detail on who leases their networks

John Carroll

For almost a decade, the American Medical Association has set its sights on eliminating what it sees as a thorn in the sides of doctors around the country — one state at a time.

Time and again, the AMA says, physicians bill for their work only to discover that the patient is covered by a payer operating off their practice’s radar at a discounted rate they had negotiated with another carrier. The AMA years ago dubbed them silent PPOs. They lease provider networks from health plans, claiming the same discounts and leaving doctors and their staffs scrambling to clarify billing arrangements.

Tough to track down

“It’s something we’ve been hearing about for years now,” says AMA Trustee Jeremy Lazarus, MD. “It’s very difficult to find out about the silent PPOs. Given the amount of time it takes for [staff members] to find out about them, doctors often just throw up their hands and say forget about it. To track these down is just mind-boggling.”

So the doctors turned to state legislatures to put an end to the practice. They’ve been making steady gains.

Over the past two years, state medical groups in Ohio, Colorado, Connecticut, Indiana, and Florida have all won passage of legislation hammering out new terms to govern these so-called silent PPOs. Now a national group of state insurance legislators has wrapped up more than two years of talks with a compromise bill that physicians from coast to coast are expected to pick up and take to their lawmakers in the next session.

The new bill spells out in detail how insurers have to offer doctors a simple method to determine who leased their networks. Members of mystery payers who can’t easily prove their status will be billed at out-of-network rates. But there are some issues yet to be resolved, chief among them being an unresolved push by the physicians to make sure that all payers operating under federal ERISA (Employee Retirement Income Security Act) rules have to comply with state law. Lazarus says health plans should also expect to hear more about the leasing issue as they sit down with physician groups for their next round of contract talks.

“About two years ago we set out to try and allow interested parties to work together and develop a model bill, but folks had their own issues. It didn’t play forward,” says Susan Nolan, executive director of the National Conference of Insurance Legislators (NCOIL).

One roadblock is downstream rentals. Providers said they never had any easy way to determine how many companies had access to the rates they had negotiated, says Nolan. Another sticking point is that self-insured plans operating under ERISA wanted to keep the exemption from state law laid out by the federal statute. The AMA felt that any compromise bill should cover all insurers, regardless of ERISA status.

Doctors complain that “they’ll have a payment show up from a payer they’ve never heard of before,” says Tim Maglione, senior director for government relations at the Ohio State Medical Association, which helped write one of the most aggressive new state laws. “I don’t have a contract; how are they paying? And then you trace back and find it was a rental arrangement. The reason they’re called silent PPOs is that you just didn’t know where this payment came from and why.”

Access allowed

In Ohio, Anthem Blue Cross & Blue Shield is the largest insurer, says Maglione. “United Healthcare has a big presence and Humana has a presence, as well as Cigna.

“I think all of those health plans in some form or fashion allow access to their networks by other payers,” he adds. “You may be a large employer in Ohio and have employees that travel or work in Michigan and Indiana, so they want to have their insurer or third-party-administrator have a network of doctors in those states where the employees may be.”

Transparency needed

“We resolved that insurers could get as much downstream rental as they wanted as long as there was transparency,” Nolan said. “So a physician could see who had gained access to discounts, and affiliates and subsidiaries should be part of the scope. Physicians should be able to refuse the rate if they can’t tell who the contracting agents are. We felt the original contracting entity had to maintain a Web site or 800 number so doctors could find out who was granted access.

“We really tried to develop a bill that balanced the need for the physicians to know what they’re going to be reimbursed for with the desire by insurers or contracting entities to be able to downstream that rental network to provide more access to folks to insurance plans,” adds Nolan. “The model we ended up with was our best attempt to provide that balance.”

Maglione, who attended the latest round of negotiations hosted by NCOIL, observes that “we don’t object to a health plan leasing their network. But if they do it, they have to follow rules. They have to be more transparent about whom they lease their networks to. There also has to be an assurance that all terms and conditions apply to the plan that leased the network. The contract flows to the new entity.”

That’s only fair, he adds. Doctors are trading discounts on their services for access to more patients as well as things like better payment terms. If someone leases the provider network a doctor is in, they have to provide the benefits — like fast payment terms, for example — as well. Individual doctors should also know about leasing arrangements so they can negotiate on that point with their insurers and perhaps gain better terms in return.

The compromise bill, though, punted on the ERISA debate. State legislators, says Nolan, will have to make that decision and work out the legalities involved.

Even without a resolution to the ERISA debate, reaching an agreement was no simple task, says Karen Greenrose, president and CEO of the American Association of Preferred Provider Organizations, which negotiated the compromise bill along with America’s Health Insurance Plans and other insurance representatives.

“We really hit some stumbling blocks,” she notes. Originally, the physicians wanted a bill that would allow individual physicians the chance to opt out every time a new customer was added to the network agreement.

Now the bill simply provides the kind of transparency the doctors have wanted, so that every time someone walks through their practice doors, they can find out which contract covers them.

“I think it’s not everything you’d want from an industry perspective,” says Greenrose. “But perhaps it’s not everything the AMA wanted either. It’s something we can work with in each state individually, to make it more effective state by state.”

ERISA

One of those issues, she readily concedes, is likely to be the ERISA preemption.

“ERISA preemption is a federal law that the states cannot ignore,” she says. “That’s what I keep going back to. Whether you like it or not, it’s there.” Any state that decides otherwise is going to have to factor in a likely legal challenge in a field with a long history of court decisions. “We’re going to work very hard to make sure that language is in every state law.”

“Anthem can have its fully insured hat on and state law applies. But when they put on their third-party-administrator hat, some question if state laws can apply because of ERISA, even though they’re doing the exact same thing,” says Maglione.

Says Lazarus: “If third party administrators are not covered [by the legislation], then 40 percent to 50 percent of a physician’s contracts aren’t covered. Doctors are going to have to be even more aware of what they’re signing.”

Silent PPOS irritate doctors because who’s paying and why that payer expects a certain rate isn’t clear, says Tim Maglione at the Ohio State Medical Association.

Health plans should expect physicians to bring up the issue of silent PPOs, says Jeremy Lazarus, MD, an AMA trustee.

Managed Care’s Top Ten Articles of 2016

There’s a lot more going on in health care than mergers (Aetna-Humana, Anthem-Cigna) creating huge players. Hundreds of insurers operate in 50 different states. Self-insured employers, ACA public exchanges, Medicare Advantage, and Medicaid managed care plans crowd an increasingly complex market.

Major health care players are determined to make health information exchanges (HIEs) work. The push toward value-based payment alone almost guarantees that HIEs will be tweaked, poked, prodded, and overhauled until they deliver on their promise. The goal: straight talk from and among tech systems.

They bring a different mindset. They’re willing to work in teams and focus on the sort of evidence-based medicine that can guide health care’s transformation into a system based on value. One question: How well will this new generation of data-driven MDs deal with patients?

The surge of new MS treatments have been for the relapsing-remitting form of the disease. There’s hope for sufferers of a different form of MS. By homing in on CD20-positive B cells, ocrelizumab is able to knock them out and other aberrant B cells circulating in the bloodstream.

A flood of tests have insurers ramping up prior authorization and utilization review. Information overload is a problem. As doctors struggle to keep up, health plans need to get ahead of the development of the technology in order to successfully manage genetic testing appropriately.

Having the data is one thing. Knowing how to use it is another. Applying its computational power to the data, a company called RowdMap puts providers into high-, medium-, and low-value buckets compared with peers in their markets, using specific benchmarks to show why outliers differ from the norm.
Competition among manufacturers, industry consolidation, and capitalization on me-too drugs are cranking up generic and branded drug prices. This increase has compelled PBMs, health plan sponsors, and retail pharmacies to find novel ways to turn a profit, often at the expense of the consumer.
The development of recombinant DNA and other technologies has added a new dimension to care. These medications have revolutionized the treatment of rheumatoid arthritis and many of the other 80 or so autoimmune diseases. But they can be budget busters and have a tricky side effect profile.

Shelley Slade
Vogel, Slade & Goldstein

Hub programs have emerged as a profitable new line of business in the sales and distribution side of the pharmaceutical industry that has got more than its fair share of wheeling and dealing. But they spell trouble if they spark collusion, threaten patients, or waste federal dollars.

More companies are self-insuring—and it’s not just large employers that are striking out on their own. The percentage of employers who fully self-insure increased by 44% in 1999 to 63% in 2015. Self-insurance may give employers more control over benefit packages, and stop-loss protects them against uncapped liability.